Harmony Biosciences Inc.
HRMY | NASDAQ
$41.99
-$0.11 (-0.26%)
Sep 22, 2026, 12:38 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 13.56 | 13.44 | 14.88 | 17.95 | 71.07 | -32.28 |
PEG Ratio | 1.74 | 0.75 | -0.51 | 0.04 | -0.46 | 0.52 |
PS Ratio | 2.48 | 2.74 | 3.30 | 7.45 | 8.03 | 12.87 |
PB Ratio | 2.47 | 2.97 | 4.11 | 8.09 | 13.15 | 21.16 |
P/FCF Ratio | 6.18 | 8.95 | 8.77 | 22.60 | 24.97 | -412.39 |
P/OCF Ratio | 6.18 | 8.90 | 8.76 | 22.57 | 24.89 | -688.97 |
OCF/S Ratio | 40.09 | 30.76 | 37.69 | 32.99 | 32.27 | -1.87 |
Debt / Equity Ratio | 0.28 | 0.28 | 0.41 | 0.48 | 1.05 | 2 |
Quick Ratio | 3.58 | 3.27 | 2.72 | 5.02 | 5.21 | 1.93 |
Current Ratio | 3.60 | 3.31 | 2.75 | 5.07 | 5.29 | 1.95 |
Asset Turnover | 0.68 | 0.72 | 0.72 | 0.65 | 0.70 | 0.37 |
Interest Coverage | 14.23 | 10.91 | 8.08 | 6.39 | 3.62 | 0.60 |
Return on Equity | 18.24% | 22.07% | 27.59% | 45.05% | 18.55% | -38.02% |
Return on Assets | 12.48% | 14.56% | 15.88% | 26.93% | 7.98% | -8.65% |
Return on Invested Capital | 13.90% | 17.20% | 21.53% | 20.13% | 21.12% | 5.81% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 77.16% | 78.06% | 79.17% | 80.93% | 81.82% | 82.64% |
Net Profit Margin | 18.27% | 20.36% | 22.14% | 41.44% | 11.33% | -23.13% |
Pretax Profit Margin | 24.76% | 26.84% | 29.79% | 23.91% | 12.25% | -23.13% |
Operating Profit Margin | 24% | 26.70% | 32.99% | 27.45% | 28.66% | 10.63% |
FCF Margin | 40.06% | 30.59% | 37.64% | 32.95% | 32.17% | -3.12% |
EBITDA Margin | 29.37% | 32.66% | 38.06% | 33.54% | 26.34% | 0.95% |
Add to Watchlist
Select watchlists to add or remove HRMY